3,4-dihydroxyphenylacetic acid has been researched along with pnu-282987 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Fischer, D; Bacher, M; Balzer-Geldsetzer, M; Dodel, RC; Noelker, C; Oertel, WH; Stuckenholz, V | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and pnu-282987
Article | Year |
---|---|
The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Bridged Bicyclo Compounds; Calcium-Binding Proteins; Chromatography, High Pressure Liquid; Corpus Striatum; Cytokines; Dopamine; Dopaminergic Neurons; Encephalitis; Enzyme-Linked Immunosorbent Assay; Homovanillic Acid; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Microfilament Proteins; Nicotinic Agonists; Parkinsonian Disorders | 2013 |